CDK6 and acute myeloid leukemia: Furthermore, downregulation or complete loss of CDK6 in AML leukemic cell lines not only decreased the rate of carcinogenesis, but also was found to be a transcriptional target of fusion protein Nucleoporin 98 (NUP98), which is often associated with poor prognosis in leukemic cancer patients [26].